LincRNAs are gaining increasing importance both as biomarkers in cancer (HOTAIR: breast [8], liver [16], pancreas [17]; MALAT-1: NSCLC [18]; PCAT-1: prostate [7]), and as regulators of complex and diverse biological functions. This evidence concerns the gene PCAT1 and non-small cell lung carcinoma.